Osteoarthritis (OA) is an age-related degenerative disease of the joint, with a hallmark of cartilage degradation. 1 No cure or treatment currently exists that offers disease-or symptommodifying effects. OA is a leading cause of disability, affecting more than 27 million Americans, and it is a significant economic burden.
Mechanical loading is an extremely important factor for cartilage homeostasis. 2 Although both underuse (eg, physically inactive lifestyle) and overuse (eg, high-impact or intense repetitive joint use) are risk factors for cartilage degradation, recent studies highlight that moderate dynamic loading is not only associated with a healthy lifestyle, but it also is a very important potential preventive and therapeutic strategy for OA by suppressing inflammation, inhibiting catabolic mediators, and enhancing anabolic activity through as-yet underexplored mechanotransduction pathways. 2 In vitro studies indicate that moderate dynamic loading reduces IL-1b-or TNF-a-induced proinflammatory gene expression, including COX-2 and IL-1b, and catabolic enzymes such as MMPs. [3] [4] [5] [6] In vivo, gentle range-of-motion exercises have been shown to mitigate joint inflammation in animal models of antigen-induced arthritis and to suppress the expression of proinflammatory and catabolic mediators. [4] [5] [6] [7] An exercise program for patients with OA that combined aerobics and strength training led to decreases in plasma inflammatory cytokine IL-6. 8 Furthermore, in vitro dynamic compression of chondrocytes seeded in hydrogels has been reported to increase expression of type II collagen, a major structural cartilage extracellular matrix protein. 9, 10 Of note, age may be an important factor in the chondrocyteanabolic response to mechanical loading. Chondrocytes isolated from juvenile (ie, 3 weeks old) bovine cartilage increased total sulfated glycosaminoglycan (sGAG) production almost three times as much as did chondrocytes isolated from adult animals (ie, 2 to 3 years old). 11 
Anti

Mechanotransduction of Chondroprotection
Elucidation of these mechanosensitive mechanisms may lead to the development of novel therapeutics to pharmacologically mimic the chondroprotective effects of moderate mechanical loading. Although mechanotransduction pathways underlying chondroprotection are not well Neither of the following authors nor any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article: Dr. Leong and Dr. Sun. understood, recent studies have shown that biomechanical signals inhibit multiple steps in the IL-b-induced cascade downstream of IkB kinase activation, regulating IkB-a and IkB-b degradation and synthesis and promoting IkB-a shuttling to export nuclear NF-kB and terminate its transcriptional activity. 12 Furthermore, induced by dynamic moderate loading, such as joint motion and joint loading in the lateral/medial direction in vivo, 5, 13 and by moderate fluid shear and intermittent hydrostatic pressure in vitro, 5,14 transactivated transcriptional factor CITED2 leads to the suppression of MMPs, at least in part through competition with MMP transactivator Ets-1 for binding to coactivator p300. 2, 5 Moreover, transient receptor potential vanilloid 4 (TRPV4), a Ca 21 -preferred membrane ion channel, acts as a transducer for loading-induced chondrocyte matrix biosynthesis. TRPV4 inhibition prevented the regulation of pro-anabolic and anti-catabolic by mechanical loading. Further, chemical activation of TRPV4 in the absence of loading mimicked the effects of moderate loading by enhancing chondrocyte anabolic activity and suppressing catabolic expression. 15 In addition to calcium signaling, proteins such as integrins and primary cilium have been suggested to be mechanotransducers of mechanical stimuli to initiate anti-catabolic and antiinflammatory signals involved in cartilage homeostasis. 16, 17 
Challenges and Future Directions
Accumulating evidence suggests that dynamic moderate exercise in patients with OA exerts symptom-modifying effects and has the potential to exert OA disease-modifying effects. Exercise may comprehensively target multiple factors involved in OA initiation and progression by enhancing anabolic activity and suppressing inflammatory and catabolic activity. However, defining a physical activity as "moderate or physiological" is a challenge because loading regimes involve many parameters, such as intensity, frequency, and duration. Additionally, the definition of "moderate" physical activity for a particular individual might vary depending on an individual's age, genetics, gender, and physical activity history. The identification of biomarkers associated with moderate loading may prove to be very useful, allowing for selection of the most appropriate form of physical activity and loading regime and therefore increasing the efficacy of mechanicalbased therapies for cartilage protection and disease modification. Furthermore, integrative approaches to elucidating the molecular mechanisms underlying physiologic loadinginduced chondroprotection could lead to the identification of novel targets for OA prevention and treatment. Such target-based therapeutics would be especially beneficial to patients with limited joint mobility and may also synergistically enhance the chondroprotective effects of moderate exercise, pharmaceuticals, and nutraceuticals.
